Cite
Huber RM, Cavic M, Kerpel-Fronius A, et al. Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An IASLC Early Detection and Screening Committee Report. J Thorac Oncol. 2021;doi: 10.1016/j.jtho.2021.11.008.
Huber, R. M., Cavic, M., Kerpel-Fronius, A., Viola, L., Field, J., Jiang, L., Kazerooni, E. A., Koegelenberg, C. F., Mohan, A., Sales Dos Santos, R., Ventura, L., Wynes, M., Yang, D., Zulueta, J., Lee, C. T., Tammemagi, C. M., Henschke, C. I., Lam, S. (2021). Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An IASLC Early Detection and Screening Committee Report. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, . https://doi.org/10.1016/j.jtho.2021.11.008
Huber, Rudolf M, et al. "Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An IASLC Early Detection and Screening Committee Report." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. (2021). doi: https://doi.org/10.1016/j.jtho.2021.11.008
Huber RM, Cavic M, Kerpel-Fronius A, Viola L, Field J, Jiang L, Kazerooni EA, Koegelenberg CF, Mohan A, Sales Dos Santos R, Ventura L, Wynes M, Yang D, Zulueta J, Lee CT, Tammemagi CM, Henschke CI, Lam S. Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An IASLC Early Detection and Screening Committee Report. J Thorac Oncol. 2021 Dec 02; doi: 10.1016/j.jtho.2021.11.008. Epub 2021 Dec 02. PMID: 34864164; PMCID: PMC8639478.
Copy
Download .nbib